NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.770
0.00 (0.00%)
At close: Jul 24, 2026, 4:00 PM EDT
1.833
+0.063 (3.54%)
After-hours: Jul 24, 2026, 7:34 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $204.7 million as of July 24, 2026. Its market cap has increased by 18.80% in one year.
Market Cap
204.70M
Enterprise Value
-3.08M
1-Year Change
18.80%
Ranking
Category
Stock Price
$1.77
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $204.70M, an increase of 48.28%. That is a compound annual growth rate of 6.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 204.70M | -55.39% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 218.00M |
| Orchestra BioMed Holdings | 217.97M |
| Minerva Neurosciences | 207.32M |
| Whitehawk Therapeutics | 205.99M |
| Atrium Therapeutics | 203.73M |
| Cellectis | 203.24M |
| Jyong Biotech | 201.17M |
| Keros Therapeutics | 200.69M |